Institution
University of Zagreb
Education•Zagreb, Grad Zagreb, Croatia•
About: University of Zagreb is a education organization based out in Zagreb, Grad Zagreb, Croatia. It is known for research contribution in the topics: Population & European union. The organization has 21769 authors who have published 50267 publications receiving 783239 citations. The organization is also known as: Zagreb University & Sveučilište u Zagrebu.
Papers published on a yearly basis
Papers
More filters
University of New South Wales1, French Institute of Health and Medical Research2, University Hospital of Bern3, Keio University4, Kurume University5, University of Paris6, University of Zagreb7, University at Buffalo8, Reims University9, New York University10, United States Department of Veterans Affairs11, University Medical Center Groningen12, University of Texas Southwestern Medical Center13, University of North Carolina at Chapel Hill14, University of Pennsylvania15, University of Southern California16, University of São Paulo17, University of Modena and Reggio Emilia18, Duke University19, Dresden University of Technology20, University of Barcelona21, Hokkaido University22, University of Utah23, Emory University24, Rabin Medical Center25, Memorial Medical Center26, University of California, Irvine27
TL;DR: Recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index, to assist in the development of consistent reporting of outcomes.
Abstract: Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.
276 citations
TL;DR: In this paper, the authors measured the transverse momentum spectra of pi(+/-), K-+/- and p((p) over bar) up to p(T) = 20 GeV/c at mid-rapidity in pp, peripheral (60-80%) and central (0-5%) Pb-Pb collisions.
276 citations
University of Bologna1, University of Belgrade2, Ljubljana University Medical Centre3, Aristotle University of Thessaloniki4, University of Latvia5, National and Kapodistrian University of Athens6, University of Debrecen7, University College London8, University of Pavol Jozef Šafárik9, University of Zagreb10, Imperial College London11, University of Palermo12, Mashhad University of Medical Sciences13, Emory University14, Johns Hopkins University15, Charles University in Prague16, University of California, Irvine17, Medical University of Łódź18
TL;DR: The purpose of this position paper is to provide consensus-based recommendations for the optimal use of lipid-lowering nutraceuticals to manage dyslipidemia in patients who are still not on statin therapy, patients who have not achieved lipid goals, and patients with statin intolerance.
Abstract: In recent years, there has been growing interest in the possible use of nutraceuticals to improve and optimize dyslipidemia control and therapy. Based on the data from available studies, nutraceuticals might help patients obtain theraputic lipid goals and reduce cardiovascular residual risk. Some nutraceuticals have essential lipid-lowering properties confirmed in studies; some might also have possible positive effects on nonlipid cardiovascular risk factors and have been shown to improve early markers of vascular health such as endothelial function and pulse wave velocity. However, the clinical evidence supporting the use of a single lipid-lowering nutraceutical or a combination of them is largely variable and, for many of the nutraceuticals, the evidence is very limited and, therefore, often debatable. The purpose of this position paper is to provide consensus-based recommendations for the optimal use of lipid-lowering nutraceuticals to manage dyslipidemia in patients who are still not on statin therapy, patients who are on statin or combination therapy but have not achieved lipid goals, and patients with statin intolerance. This statement is intended for physicians and other healthcare professionals engaged in the diagnosis and management of patients with lipid disorders, especially in the primary care setting.
274 citations
Westinghouse Electric1, Polytechnic University of Milan2, National Nuclear Energy Commission3, Entertainments National Service Association4, Ansaldo STS5, Massachusetts Institute of Technology6, University of Zagreb7, Tennessee Valley Authority8, Tokyo Institute of Technology9, Oak Ridge National Laboratory10, University of Pisa11
TL;DR: The International Reactor Innovative and Secure (IRIS) as discussed by the authors is an integral, modular, medium size (335 MWe) PWR, which has been under development since the turn of the century by an international consortium led by Westinghouse and including over 20 organizations from nine countries.
274 citations
University of Nottingham1, University of Leicester2, Ludwig Institute for Cancer Research3, Queen Mary University of London4, Imperial College London5, National Institutes of Health6, King's College London7, Western General Hospital8, Uppsala University9, University of Oulu10, University of Toronto11, Ontario Institute for Cancer Research12, Sir Charles Gairdner Hospital13, University of Western Australia14, University of South Florida15, St George's, University of London16, University of Bristol17, Wellcome Trust Sanger Institute18, University of Cambridge19, University of Greifswald20, University of Split21, University of Zagreb22, University of Edinburgh23, University of Basel24, Swiss Tropical and Public Health Institute25, University of Helsinki26, University of Jyväskylä27
TL;DR: Polymorphisms spanning previously associated lung function genes did not show strong evidence for association with lung function measures in the SpiroMeta consortium population of 20,288 individuals from the general population.
Abstract: Rationale: Lung function measures are heritable traits that predict population morbidity and mortality and are essential for the diagnosis of chronic obstructive pulmonary disease (COPD). Variations in many genes have been reported to affect these traits, but attempts at replication have provided conflicting results. Recently, we undertook a meta-analysis of Genome Wide Association Study (GWAS) results for lung function measures in 20,288 individuals from the general population (the SpiroMeta consortium).
274 citations
Authors
Showing all 22096 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Harry Campbell | 150 | 897 | 115457 |
| Joseph R. Ecker | 148 | 381 | 94860 |
| Igor Rudan | 142 | 658 | 103659 |
| Nikola Godinovic | 138 | 1469 | 100018 |
| Ivica Puljak | 134 | 1436 | 97548 |
| Damir Lelas | 133 | 1354 | 93354 |
| Željko Ivezić | 129 | 344 | 84365 |
| Piotr Ponikowski | 120 | 762 | 131682 |
| Marin Soljacic | 117 | 764 | 51444 |
| Ivan Dikic | 107 | 359 | 52088 |
| Ozren Polasek | 102 | 436 | 52674 |
| Mordechai Segev | 99 | 729 | 40073 |
| Srdan Verstovsek | 96 | 1045 | 38936 |
| Segev BenZvi | 95 | 482 | 32127 |
| Mirko Planinic | 94 | 467 | 31957 |